NOIR Spectrashield Medium Fit-Over 87% Yellow
by NoIR Medical
Last verified June 18, 2026 · classified April 26, 2026
What it is
Summary
AI-generated from vendor-published content · April 26, 2026
These are tinted fit-over glasses designed to be worn over prescription eyewear, using a yellow filter that blocks blue light and UV while significantly increasing perceived contrast and brightness. They're intended for people with low vision conditions — such as macular degeneration, diabetic retinopathy, or cataracts — where glare sensitivity and reduced contrast make daily tasks difficult. The medium frame fits over most standard prescription glasses and includes side shields to reduce peripheral glare. The 87% yellow filter increases brightness but is not suitable for bright outdoor sun environments — it's better suited for indoor or overcast conditions.
Quick Facts Catalog facts · auto-generated
- AT Act lending
- Out of pocket
- Vocational rehab
What Setup Looks Like
- Out of the box
Slide over existing prescription glasses and adjust the temples for a secure fit — ready to use immediately. - With professional help
A low vision specialist or optometrist can help determine which filter percentage and color works best for your specific condition and lighting environments.
Getting it
Try Before You Buy
Devices like this are often available to borrow through your state's AT Act program — typically free or low-cost — so you can try it before buying or pursuing funding.
Where to Get It
Some links may be affiliate links — WhatCanHelp may earn a small commission from purchases at no extra cost to you. More on affiliates →
As an Amazon Associate we earn from qualifying purchases.
How to Fund This
Equipment like this is often pursued through official state programs. These are common starting points — each program decides its own eligibility and what it covers, so the first step is always a phone call.
Compare & explore
Sources & fine print
Vendor facts (name, price, platforms, vendor link) sourced from NoIR Medical — view on vendor site; last verified June 18, 2026.
Classification & description AI-generated from vendor-published content on April 26, 2026 · confidence: high. Vendor specs may lag; verify before relying on details in a clinical or funding artifact.